Moreover, we blocked the function of CD44 in AF1q-overexpressing CML cells and found attenuated survival activities and sensitivity to IM in these cells, which partially counteracted the deleterious effects of AF1q. This evidence concerns the gene CD44 and chronic myelogenous leukemia, BCR-ABL1 positive.